67 related articles for article (PubMed ID: 7503622)
1. [Calcium antagonists and prevention of post-angioplasty restenosis].
Hoberg E
Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():29-34. PubMed ID: 7503622
[TBL] [Abstract][Full Text] [Related]
2. Calcium-antagonists in preventing restenosis following coronary angioplasty.
Hoberg E; Kübler W
Cardiologia; 1991 Dec; 36(12 Suppl 1):225-7. PubMed ID: 1841774
[TBL] [Abstract][Full Text] [Related]
3. Prevention of restenosis after PTCA: role of calcium antagonists.
Hoberg E; Kübler W
J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S15-9. PubMed ID: 1725911
[TBL] [Abstract][Full Text] [Related]
4. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
Kocurek A; Piwowarska W
Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
[TBL] [Abstract][Full Text] [Related]
5. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
Dens J; Desmet W; Piessens J
Am Heart J; 2003 Mar; 145(3):404-8. PubMed ID: 12660661
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty.
Schlant RC; King SB
Circulation; 1989 Dec; 80(6 Suppl):IV88-92. PubMed ID: 2688988
[TBL] [Abstract][Full Text] [Related]
7. Enalapril for prevention of restenosis after coronary angioplasty.
Kaul U; Chandra S; Bahl VK; Sharma S; Wasir HS
Indian Heart J; 1993; 45(6):469-73. PubMed ID: 8070823
[TBL] [Abstract][Full Text] [Related]
8. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
Jørgensen B; Thaulow E;
Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
[TBL] [Abstract][Full Text] [Related]
9. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
10. [Preventive mechanisms and effects of pemirolast potassium on restenosis after percutaneous transluminal coronary angioplasty: serial coronary angiography and intravascular ultrasound studies].
Yoshinuma M
J Cardiol; 1999 Feb; 33(2):81-8. PubMed ID: 10087476
[TBL] [Abstract][Full Text] [Related]
11. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Preisack MB; Karsch KR
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.
Zohlnhöfer D; Hausleiter J; Kastrati A; Mehilli J; Goos C; Schühlen H; Pache J; Pogatsa-Murray G; Heemann U; Dirschinger J; Schömig A
J Am Coll Cardiol; 2005 Dec; 46(11):1999-2003. PubMed ID: 16325031
[TBL] [Abstract][Full Text] [Related]
13. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
14. The effects of calcium antagonists after PTCA.
Hoberg E
Eur Heart J; 1995 Aug; 16 Suppl H():9-12. PubMed ID: 8846803
[TBL] [Abstract][Full Text] [Related]
15. Prevention of restenosis by bezafibrate after successful coronary angioplasty.
Ishiwata S; Nakanishi S; Nishiyama S; Seki A
Coron Artery Dis; 1995 Nov; 6(11):883-9. PubMed ID: 8696533
[TBL] [Abstract][Full Text] [Related]
16. Effect of high dose verapamil on restenosis after peripheral angioplasty.
Schweizer J; Kirch W; Koch R; Hellner G; Uhlmann K
J Am Coll Cardiol; 1998 May; 31(6):1299-305. PubMed ID: 9581724
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
Mood GR; Bavry AA; Roukoz H; Bhatt DL
Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
[TBL] [Abstract][Full Text] [Related]
18. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial].
Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G
J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098
[TBL] [Abstract][Full Text] [Related]
19. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
Peters S; Götting B; Trümmel M; Rust H; Brattström A
J Invasive Cardiol; 2001 Feb; 13(2):93-7. PubMed ID: 11176015
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty.
Grassman ED; Leya F; Fareed J; Lewis BE; Bacher P; Loeb HS; Moran JF
J Invasive Cardiol; 2001 Nov; 13(11):723-8. PubMed ID: 11689712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
